As of 2026-03-06, the Relative Valuation of AtriCure Inc (ATRC) is (7.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 30.31 USD, the upside of AtriCure Inc based on Relative Valuation is -124.5%.
The range of the Relative Valuation is (7.48) - (7.51) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.5x - 40.4x | 37.0x |
| Forward P/E multiples | 22.6x - 32.6x | 27.4x |
| Fair Price | (7.48) - (7.51) | (7.41) |
| Upside | -124.7% - -124.8% | -124.5% |
| Date | P/E |
| 2026-03-03 | -136.63 |
| 2026-03-02 | -134.33 |
| 2026-02-27 | -135.77 |
| 2026-02-26 | -137.42 |
| 2026-02-25 | -135.46 |
| 2026-02-24 | -135.24 |
| 2026-02-23 | -138.07 |
| 2026-02-20 | -141.50 |
| 2026-02-19 | -140.63 |
| 2026-02-18 | -140.11 |
| 2026-02-17 | -143.19 |
| 2026-02-13 | -141.80 |
| 2026-02-12 | -138.11 |
| 2026-02-11 | -142.87 |
| 2026-02-10 | -164.43 |
| 2026-02-09 | -160.35 |
| 2026-02-06 | -161.17 |
| 2026-02-05 | -157.22 |
| 2026-02-04 | -159.83 |
| 2026-02-03 | -165.34 |
| 2026-02-02 | -159.91 |
| 2026-01-30 | -160.39 |
| 2026-01-29 | -160.48 |
| 2026-01-28 | -164.04 |
| 2026-01-27 | -166.82 |
| 2026-01-26 | -167.25 |
| 2026-01-23 | -169.69 |
| 2026-01-22 | -173.81 |
| 2026-01-21 | -170.55 |
| 2026-01-20 | -166.86 |
| 2026-01-16 | -169.64 |
| 2026-01-15 | -180.07 |
| 2026-01-14 | -162.30 |
| 2026-01-13 | -158.09 |
| 2026-01-12 | -163.47 |
| 2026-01-09 | -180.07 |
| 2026-01-08 | -184.17 |
| 2026-01-07 | -181.41 |
| 2026-01-06 | -179.98 |
| 2026-01-05 | -175.98 |
| 2026-01-02 | -170.55 |
| 2025-12-31 | -171.81 |
| 2025-12-30 | -174.51 |
| 2025-12-29 | -175.57 |
| 2025-12-26 | -175.16 |
| 2025-12-24 | -176.11 |
| 2025-12-23 | -176.07 |
| 2025-12-22 | -180.89 |
| 2025-12-19 | -177.85 |
| 2025-12-18 | -175.46 |